In the most recent episode of the hit HBO show The White Lotus, Jason Isaacs ‘ character Timothy Ratliff wears a T-shirt with ...

SURESNES, France and CAMBRIDGE, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Servier, an independent global pharmaceutical group governed by a non-profit foundation, and Black Diamond Therapeutics ...

Servier and Black Diamond Therapeutics (BDTX) announced a strategic worldwide licensing agreement for BDTX-4933, a potential best-in-class targeted therapy for solid tumors. Under this global ...

Five months after cutting support for BDTX-4933, the biotech has licensed the RAF inhibitor to Servier for $70 million upfront and up to $710 million in milestones. In October, Black Diamond ...

SURESNES, France and CAMBRIDGE, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Servier, an independent global pharmaceutical group governed by a non-profit foundation, and Black Diamond Therapeutics, Inc. ...

Servier will lead the development activities and the worldwide commercialization of BDTX-4933 across multiple indications. Currently, in Phase 1 development, BDTX-4933 is designed to target RAS ...

Snow White opens in theaters Friday, March 21. While it’s technically the latest in Disney’s never-ending string of live-action remakes, Snow White is more adaptation than mere nostalgic mimicry.

After raiding the crown jewels for just about every live-action reboot imaginable, Disney has finally gotten around to the one that started it all, the 1937 classic Snow White and the Seven Dwarfs.

“Snow White” has officially hit theaters and Disney fans have some thoughts. The new film, starring Rachel Zegler as the titular role and Gal Gadot as the Evil Queen, is the live-action take ...

"More than ever, with Servier 2030, we are focused on innovation and positive social impact thanks to an improved profitability and bold choices." Image Phil Taylor ...

Pieris Pharmaceuticals’ long-standing immuno-oncology alliance with Servier is being dissolved after a clinical trial of the lead drug in the alliance revealed a safety concern. In a Securities ...